China SXT Pharmaceuticals, Inc. (SXTC): Price and Financial Metrics


China SXT Pharmaceuticals, Inc. (SXTC)

Today's Latest Price: $0.40 USD

0.00 (-0.70%)

Updated Jun 2 4:00pm

Add SXTC to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 214 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

SXTC Stock Summary

  • SXTC's went public 1.41 years ago, making it older than merely 1.68% of listed US stocks we're tracking.
  • With a price/sales ratio of 43.13, China SXT Pharmaceuticals Inc has a higher such ratio than 96.15% of stocks in our set.
  • As for revenue growth, note that SXTC's revenue has grown -83.89% over the past 12 months; that beats the revenue growth of only 1.33% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to China SXT Pharmaceuticals Inc, a group of peers worth examining would be VALU, ASFI, NPK, ENZN, and NWLI.
  • To dig deeper into the stock's financial statements, go to SXTC's page on browse-edgar?action=getcompany&CIK=0001723980.
SXTC Daily Price Range
SXTC 52-Week Price Range

SXTC Stock Price Chart More Charts


SXTC Price/Volume Stats

Current price $0.40 52-week high $5.00
Prev. close $0.40 52-week low $0.34
Day low $0.38 Volume 1,977,938
Day high $0.41 Avg. volume 2,280,656
50-day MA $0.46 Dividend yield N/A
200-day MA $1.01 Market Cap 11.09M

China SXT Pharmaceuticals, Inc. (SXTC) Company Bio


China Sxt Pharmaceuticals, Inc. engages in the development, manufacture, marketing, sales, research and development of Chinese traditional medicine. It sells Advanced TCMP, Fine TCMP and Regular TCMP products. The company sell its products under "Suxuantang" brand name. The company was founded by Zhou Feng in 2005 and is headquartered in Taizhou, China.


SXTC Latest News Stream


Event/TimeNews Detail
Loading, please wait...

SXTC Latest Social Stream


Loading social stream, please wait...

View Full SXTC Social Stream

Latest SXTC News From Around the Web

Below are the latest news stories about China SXT Pharmaceuticals Inc that investors may wish to consider to help them evaluate SXTC as an investment opportunity.

Hedge Funds Warming Up To China SXT Pharmaceuticals, Inc. (SXTC)

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

Yahoo | May 29, 2020

China SXT Pharmaceuticals, Inc. Announces That It Received a Grant Supported by City Government

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS") announced today that a fund granted to the Company for the key techniques incorporated into advanced Directly-Oral TCMPs derived from agriculture has been approved on February 19, 2020, by the Hailing District Science and Technology Bureau of Taizhou city.

Yahoo | March 16, 2020

How Does China SXT Pharmaceuticals's (NASDAQ:SXTC) P/E Compare To Its Industry, After Its Big Share Price Gain?

China SXT Pharmaceuticals (NASDAQ:SXTC) shares have had a really impressive month, gaining 45%, after some slippage...

Yahoo | January 28, 2020

China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory

China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements ("TCMHS") announced today that its DNA Exam Laboratory completely built in October of 2019 recently has been approved by Jiangsu province Drug Administration (JSDA). The Laboratory has been granted to perform research and development (R&D;) and quality control of TCM raw materials and TCMP products applying DNA testing technology.

Yahoo | January 16, 2020

China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency

China SXT Pharmaceuticals, Inc. ("SXTC" or the "Company"), (NASDAQ: SXTC) announced today that on December 27, 2019 the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that the minimum bid price per share for its common shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).

Yahoo | January 3, 2020

Read More 'SXTC' Stories Here

SXTC Price Returns

1-mo -8.26%
3-mo -55.88%
6-mo -47.37%
1-year -89.30%
3-year N/A
5-year N/A
YTD -51.22%
2019 N/A
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Continue Researching SXTC

Here are a few links from around the web to help you further your research on China SXT Pharmaceuticals Inc's stock as an investment opportunity:

China SXT Pharmaceuticals Inc (SXTC) Stock Price | Nasdaq
China SXT Pharmaceuticals Inc (SXTC) Stock Quote, History and News - Yahoo Finance
China SXT Pharmaceuticals Inc (SXTC) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9603 seconds.